These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Octreotide: a somatostatin analog. Salman K; Rose LI Am Fam Physician; 1989 Jun; 39(6):207-11. PubMed ID: 2543196 [No Abstract] [Full Text] [Related]
3. [Theoretical and physiopharmacological bases of the somatostatin treatment in digestive diseases]. Consolo F; Pustorino S Minerva Chir; 1992 Apr; 47(8):723-9. PubMed ID: 1351277 [No Abstract] [Full Text] [Related]
4. [Somatostatin and its analogs in the treatment of gastrointestinal and liver diseases]. Feu F; Bosch J Gastroenterol Hepatol; 1996 Feb; 19(2):68-77. PubMed ID: 8616683 [No Abstract] [Full Text] [Related]
7. [Advances in gastrointestinal peptides: somatostatin]. Ubilluz R Rev Gastroenterol Peru; 1993; 13(3):178-85. PubMed ID: 7910493 [TBL] [Abstract][Full Text] [Related]
8. Octreotide--a synthetic somatostatin. Med Lett Drugs Ther; 1989 Jul; 31(796):66-8. PubMed ID: 2567960 [No Abstract] [Full Text] [Related]
9. [Management of insulinoma with the somatostatin analog SMS 201-995]. Gilsanz Peral A; Gómez Balaguer M; Costa Talens P Med Clin (Barc); 1988 Apr; 90(15):634-5. PubMed ID: 2899658 [No Abstract] [Full Text] [Related]
10. [Somatostatin. II: Physiology, pathophysiology and clinical significance]. Ratzmann KP; Zühlke H Z Gesamte Inn Med; 1981 Jan; 36(2):55-8. PubMed ID: 6111869 [TBL] [Abstract][Full Text] [Related]
11. Somatostatin and its analogues in G.I. tract, liver and pancreatic disorders. Dhar A; Chawla YK Trop Gastroenterol; 1995; 16(3):3-7. PubMed ID: 8838035 [No Abstract] [Full Text] [Related]
12. Somatostatin and analogues in the treatment of VIPoma. O'Dorisio TM; Gaginella TS; Mekhjian HS; Rao B; O'Dorisio MS Ann N Y Acad Sci; 1988; 527():528-35. PubMed ID: 2898913 [No Abstract] [Full Text] [Related]
13. Somatostatin inhibition of insulin and gastrin hypersecretion in pancreatic islet-cell carcinoma. Curnow RT; Carey RM; Taylor A; Johanson A; Murad F N Engl J Med; 1975 Jun; 292(26):1385-6. PubMed ID: 166308 [No Abstract] [Full Text] [Related]
14. Somatostatin: diabetes and acromegaly. Gerich JE Adv Intern Med; 1977; 22():251-72. PubMed ID: 190870 [No Abstract] [Full Text] [Related]
15. [Therapeutic use of beta-blockers in general pathology (rheumatology, neurology and ophthalmology) (author's transl)]. Bouvenot G; Bartolin R; Escande M; Delboy C Therapie; 1980; 35(1):61-81. PubMed ID: 6106303 [No Abstract] [Full Text] [Related]
17. [Somatostatin: the important factor for regulating digestive functions]. Li YY; Gao JT Sheng Li Ke Xue Jin Zhan; 1995 Jan; 26(1):65-8. PubMed ID: 7604227 [No Abstract] [Full Text] [Related]
18. Somatostatin and the gastrointestinal tract. Arnold R; Lankisch PG Clin Gastroenterol; 1980 Sep; 9(3):733-53. PubMed ID: 6107192 [No Abstract] [Full Text] [Related]
19. Diabetes mellitus and somatostatin. A review. Lundbaek K; Hansen AP Dan Med Bull; 1977 Feb; 24(1):1-7. PubMed ID: 837735 [No Abstract] [Full Text] [Related]
20. Evaluation of somatostatin and the somatostatin analogue octreotide as therapeutic agents in gastrointestinal disorders. Masclee AA; Jansen JB; Lamers CB Neth J Med; 1991 Dec; 39(5-6):356-65. PubMed ID: 1687076 [No Abstract] [Full Text] [Related] [Next] [New Search]